NCT06383195

Brief Summary

This study assesses the test-retest reliability, construct validity, and minimal detectable change of the Ankylosing Spondylitis Performance Index (ASPI) in assessing the physical function of patients with Enthesitis-related arthritis (ERA).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 21, 2024

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 17, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2026

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

2 years

First QC Date

April 17, 2024

Last Update Submit

April 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ankylosing Spondylitis Performance Index (ASPI)

    The ASPI is performed in a common consultation room and consists of 3 standardized performance tasks: (1) bending to pick up 6 pencils from the floor (one by one); (2) putting on socks (mean of 3 times); and (3) getting up from the floor (mean of 3 times). The completion time for each task in the test will be recorded in seconds. The pain the patient feels during each task in the test will be evaluated using the Numeric Rating Scale (NRS) (0: no pain and 10: extreme pain). In addition, the patient's exertion in each task in the test will be evaluated using the Borg scale (0: no exertion and 10: extreme exertion).

    Baseline (First assessment)

Secondary Outcomes (5)

  • Childhood Health Assessment Questionnaire (CHAQ)

    Baseline (First assessment)

  • Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

    Baseline (First assessment)

  • Bath Ankylosing Spondylitis Functional Index (BASFI)

    Baseline (First assessment)

  • Bath Ankylosing Spondylitis Metrology Index (BASMI)

    Baseline (First assessment)

  • Modified Paediatric Mini Mental Scale (MPMMS)

    Baseline (First assessment)

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Enthesitis-related arthritis (ERA)

You may qualify if:

  • Being diagnosed with Enthesitis-Related Arthritis (ERA) according to The International League of Associations for Rheumatology (ILAR) classification
  • Being between the ages of 7-18
  • Volunteering to participate in research

You may not qualify if:

  • Advanced heart/lung/liver/kidney disease, neurological disease and malignancies
  • Having undergone major orthopedic surgery
  • The presence of moderate to severe mental problems that will negatively affect participation
  • Not volunteering to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Arthritis, Juvenile

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Sinan Buran, RA

    Hacettepe University Faculty of Physical Therapy and Rehabilitation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 17, 2024

First Posted

April 25, 2024

Study Start

March 21, 2024

Primary Completion

March 20, 2026

Study Completion

March 20, 2026

Last Updated

April 25, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations